Suppliers / Solupharm Pharmazeutische Erzeugnisse

Solupharm Pharmazeutische Erzeugnisse

Germany 110 employees Updated 9 July 2026

Solupharm Pharmazeutische Erzeugnisse is a finished-dose manufacturer based in Germany. It appears in 92 regulatory filings across 15 regulators, without an active US DMF or CEP on file. Its filings concentrate with EMA, DIGEMAPS (DO) and EDE (AE). Its GMP standing is certified by ZLG (DE), EMA and EAEU_EEC, among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 29 July 2022 as VAI.

0
active US DMFs
0
valid CEPs
8
registered plants 1 with an FDA FEI number
92
filings across 15 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
5 of 5 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 29 July 2022 VAI US FDA
  • 2 February 2018 VAI US FDA
  • 21 June 2016 VAI US FDA
  • 22 September 2014 VAI US FDA
  • 22 November 2011 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Ismaning, United Arab Emirates Not on file
Melsungen, United Arab Emirates Not on file
34212 Melsungen, United Arab Emirates Not on file
Ismaning, Germany Not on file
Bavaria, Germany Not on file
MELSUNGEN, Germany Not on file

2 further sites are on record.

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA 30 3
DIGEMAPS (DO) 17 None
EDE (AE) 10 None
ARCSA (EC) 5 None
NPRA (MY) 5 None
MINSA (CR) 5 None
ZLG (DE) None 18
EAEU_EEC None 3
ANVISA (Brazil) None 2

Comparing suppliers?

Choose your molecules and target markets. Solupharm Pharmazeutische Erzeugnisse comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 29 July 2022.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates